Ms. Shapira is a Managing Director, Consumer Health Strategy at Hildred Capital Management, LLC. Prior to joining Hildred, Ms. Shapira served as a Founding Managing Director of Eurazeo Brands, an $800 million investment division of Eurazeo, a French private equity firm, from 2017 to 2023, where she focused on consumer brands. During her tenure, she served on the boards of NEST Fragrances, Herschel Supply Company, Dewey s Cookies and Beekman 1802. Previously, Ms. Shapira was Chief Financial Officer of David Yurman, a luxury jewelry company, from 2012 to 2016. While there, she played a key role in transitioning the family-owned brand from a wholesale model to direct-to-consumer channels, including retail stores and e-commerce. Prior to that, she spent 13 years at Goldman Sachs as a Managing Director in Equity Research, covering the Broadlines Retail Sector, which included 27 public companies across luxury brands, department stores, discounters, mass retailers, dollar stores, warehouse clubs and grocers. Earlier in her career, Ms. Shapira was an equity analyst at Robertson Stephens and Neuberger Berman. Ms. Shapira has extensive expertise in finance, accounting and financial reporting, is a qualified financial expert, and brings senior leadership experience complemented by a strong background in marketing and brand management. Current Directorships: Crown Laboratories, Inc., Hildred Portfolio Companies: Hyland s and Revance Former Directorships: The Hain Celestial Group, Inc., Kohl s Corporation Age: 67 Director Since: 2013 Committees: Compensation, Strategy & Investment